Financhill
Back

PTC Therapeutics Vs. Crinetics Pharmaceuticals Industry Stock Comparison

Sell
40

PTCT
PTC Therapeutics

Last Price:
37.52
Seasonality Move:
3.92%
Sell
34

CRNX
Crinetics Pharmaceuticals

Last Price:
50.72
Seasonality Move:
14.3%
Sell
40
PTC Therapeutics (PTCT) is a Sell

Is PTC Therapeutics a Buy, Sell or Hold?

  • The current PTC Therapeutics [PTCT] share price is $37.56. The Score for PTCT is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.
  • PTCT is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
34
Crinetics Pharmaceuticals (CRNX) is a Sell

Is Crinetics Pharmaceuticals a Buy, Sell or Hold?

  • The current Crinetics Pharmaceuticals [CRNX] share price is $50.75. The Score for CRNX is 34, which is 32% below its historic median score of 50, and infers higher risk than normal.
  • CRNX is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

PTCT Stock Price Chart

What is PTC Therapeutics's stock price today?

  • The PTC Therapeutics share price today is $37.56
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and PTCT is experiencing slight selling pressure.

CRNX Stock Price Chart

What is Crinetics Pharmaceuticals's stock price today?

  • The Crinetics Pharmaceuticals share price today is $50.75
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CRNX is experiencing slight selling pressure.

PTCT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 1.06 Buy
Relative Strength Index (14 RSI): 69.28 Buy
Chaikin Money Flow: -221691 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (32.67 - 36.49) Buy
Bollinger Bands (100): (31.89 - 36.41) Buy

CRNX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.3 Sell
Relative Strength Index (14 RSI): 45.77 Sell
Chaikin Money Flow: -79785 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (50.74 - 53.6) Sell
Bollinger Bands (100): (46.49 - 53.25) Buy

PTCT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 36.67 Buy
20-day SMA: 34.47 Buy
50-day SMA: 33.72 Buy
200-day SMA: 31.08 Buy
8-day EMA: 36.52 Buy
20-day EMA: 35.25 Buy
50-day EMA: 34.22 Buy
200-day EMA: 32.66 Buy

CRNX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 51.48 Sell
20-day SMA: 51.82 Sell
50-day SMA: 52.07 Sell
200-day SMA: 45.02 Buy
8-day EMA: 51.18 Sell
20-day EMA: 51.71 Sell
50-day EMA: 51.34 Sell
200-day EMA: 44.69 Buy

PTC Therapeutics Earnings Growth & PTCT Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.13 per share, an increase next quarter of $0.67 per share, an increase this year of $0.38 per share, and an increase next year of $0.67 per share.

Crinetics Pharmaceuticals Earnings Growth & CRNX Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.03 per share, a decrease next quarter of $0.16 per share, a decrease this year of $0.05 per share, and a decrease next year of $0.25 per share.

PTC Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Crinetics Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):